Search Results - caleb+bupp

1 Results Sort By:

Polyamine-Based Therapeutic Approach for Alopecia Areata

Executive Summary: Oral administration of DFMO (Eflornithine), a polyamine inhibitor, offers a novel treatment to reduce elevated polyamine levels and stimulate hair regrowth in alopecia areata patients. Description: Alopecia areata is an autoimmune hair loss disorder that affects approximately 5 million patients in the United States. Laboratory...
Published: 4/17/2026   |   Inventor(s): Andre Bachmann, Caleb Bupp
Keywords(s):   Category(s): Medical, Pharmaceutical, Therapeutic